百科

(4R,5R)-4,5-isopropylidenedioxypentadecanol

(4R,5R)-4,5-isopropylidenedioxypentadecanol

CAS号：202067-10-5

英文名：(4R,5R)-4,5-isopropylidenedioxypentadecanol

分子式

C18H36O3

熔点

密度

分子量

300.477

沸点

溶解度

信号词

危险品标志

若想填写更详细的询价信息，请点击进入询价页面

点我

基本信息

中文名称

(4R,5R)-4,5-isopropylidenedioxypentadecanol

英文名称

(4R,5R)-4,5-isopropylidenedioxypentadecanol

中文别名

英文别名

3-((4R,5R)-5-Decyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-propan-1-ol

CAS号

202067-10-5

分子式

C18H36O3

分子量

300.477

精确质量

300.266

PSA

38.69

LOGP

4.8098

下游产品

共找到8个下游商品 >

(4R,5R,8R,9R,12R,13S)-13-(4-nitrobenzoyloxy)-5,8:9,12-dioxidotricosa-1,4-olide

(4R,5R,8R,9R,12R,13S)-13-(4-nitrobenzoyloxy)-5,8:9,12-dioxidotricosa-1,4-olide

(5S)-3-[(2S,13R)-2,13-二羟基-13-[(2R,5R)-5-[(2R,5R)-5-[(1R)-1-羟基十一烷基]四氢呋喃-2-基]四氢呋喃-2-基]十三烷基]-5-甲基-5H-呋喃-2-酮

(5S)-3-[(2S,13R)-2,13-二羟基-13-[(2R,5R)-5-[(2R,5R)-5-[(1R)-1-羟基十一烷基]四氢呋喃-2-基]四氢呋喃-2-基]十三烷基]-5-甲基-5H-呋喃-2-酮

Benzoic acid 2-benzenesulfonyl-4-((4R,5R)-5-dec-9-enyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-1-[2-((4R,5R)-5-decyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-ethyl]-butyl ester

Benzoic acid 2-benzenesulfonyl-4-((4R,5R)-5-dec-9-enyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-1-[2-((4R,5R)-5-decyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-ethyl]-butyl ester

trilobacin

(S)-3-{(E)-(R)-11-Hydroxy-11-[(2R,5R,2'R,5'R)-5'-((R)-1-hydroxy-undecyl)-octahydro-[2,2']bifuranyl-5-yl]-undec-2-enyl}-5-methyl-5H-furan-2-one

(S)-3-{(E)-(R)-11-Hydroxy-11-[(2R,5R,2'R,5'R)-5'-((R)-1-hydroxy-undecyl)-octahydro-[2,2']bifuranyl-5-yl]-undec-2-enyl}-5-methyl-5H-furan-2-one

(3S,4S)-1-((4R,5R)-5-Dec-9-enyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-6-((4R,5R)-5-decyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-hexane-3,4-diol

(3S,4S)-1-((4R,5R)-5-Dec-9-enyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-6-((4R,5R)-5-decyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-hexane-3,4-diol

下游产品

(4R,5R,8R,9R,12R,13S)-13-(4-nitrobenzoyloxy)-5,8:9,12-dioxidotricosa-1,4-olide (5S)-3-[(2S,13R)-2,13-二羟基-13-[(2R,5R)-5-[(2R,5R)-5-[(1R)-1-羟基十一烷基]四氢呋喃-2-基]四氢呋喃-2-基]十三烷基]-5-甲基-5H-呋喃-2-酮 Benzoic acid 2-benzenesulfonyl-4-((4R,5R)-5-dec-9-enyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-1-[2-((4R,5R)-5-decyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-ethyl]-butyl ester trilobacin (S)-3-{(E)-(R)-11-Hydroxy-11-[(2R,5R,2'R,5'R)-5'-((R)-1-hydroxy-undecyl)-octahydro-[2,2']bifuranyl-5-yl]-undec-2-enyl}-5-methyl-5H-furan-2-one (3S,4S)-1-((4R,5R)-5-Dec-9-enyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-6-((4R,5R)-5-decyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-hexane-3,4-diol (2R,2'S,5'S)-5'-[(R)-3-((4R,5R)-5-Decyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-1-hydroxy-propyl]-tetrahydro-[2,2']bifuranyl-5-one (S)-5-Methyl-3-{(2S,3S,11R)-2,3,11-trihydroxy-11-[(2R,5R,2'R,5'R)-5'-((R)-1-hydroxy-undecyl)-octahydro-[2,2']bifuranyl-5-yl]-undecyl}-5H-furan-2-one